Blog Posts

Follow along as we discuss the latest changes across the pharmaceutical, biotechnology, medical technology and life science sectors.

  • The Pointy End of the TGA (PI) Reformatting Transition Period

    The Pointy End of the TGA (PI) Reformatting Transition Period

    By now, we should all be very familiar with the new Form for providing Product Information (PI) for Australia. Each time you make a change to a PI, be it safety-related or otherwise, you’re required to provide the updated PI to TGA in the new format. The looming deadline for marketed product PIs to be

  • Therapeutic Product Commercialization Strategy

    Therapeutic Product Commercialization Strategy

    We may have a global market but do we really consider options outside of USA and EU when developing our Therapeutic Product Commercialization strategy? The USA, EU/UK are large markets with clear regulatory requirements, so they are often first targets for therapeutic product commercialization, either for medicines or medical devices.  A New Perspective But what

  • Australian Employment Regulations

    Australian Employment Regulations

    Today, we are pleased to introduce one of our affiliates and guest blogger, Anna Pannuzzo from WorkPlacePLUS. In this post, Anna discusses some key workplace health, safety and other legal aspects of setting up or maintaining a sales office in Australia. Expanding your business can be an exciting time, but setting up abroad comes with…

  • Advertizing Therapeutic Goods in Australia

    Advertizing Therapeutic Goods in Australia

    If you’re advertizing therapeutic goods in Australia in 2019, there’s new legislation that is critical to your successful campaign/s. We’ve been keeping up to date over the break to ensure we’re ready to assist our clients with all of their commercialization needs around the globe.